文献速递免疫规划传染病防控与疫情报告

CCL3、CCL5、IL-15、IL-1Ra与VEGF组成可靠算法鉴别17DD-YF初免后不良事件类别

CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions.
PubMed 文献 · Vaccine · 2021-06-16

本研究在黄热病免疫后不良事件(YEL-AEFI)疑似病例中量化多种血清生物标志物,提出实验室算法以区分确诊YEL-AEFI(A1类)与其他疾病(C类)。结果显示CCL3、CCL5、IL-15和IL-1Ra区分A1与C的AUC达1.00,决策树算法总体准确率91%,VEGF可进一步区分野生型YFV感染。

要点

  • CCL3、CCL5、IL-15、IL-1Ra区分YEL-AEFI确诊(A1)与其他疾病(C)的AUC为1.00。
  • 决策树算法鉴别YEL-AEFI病因特异性定义的总体准确率为91%。
  • VEGF作为分支节点可区分野生型YFV感染(C(WT-YFV))与其他疾病(C*)。

核心结论

  • 血清生物标志物组合可作为YEL-AEFI病例补充鉴别诊断的候选实验室工具。

研究设计与样本

  • 在YEL-AEFI疑似病例中量化一组血清生物标志物,比较YEL-AEFI(A1和C类)与无YEL-AEFI的初免接种者[PV(day 3-28)]及参考范围(RR)对照。

主要发现

  • 与PV(day 3-28)和RR对照相比,YEL-AEFI(A1和C类)中CXCL8、CCL2、CXCL10、IL-1β、IL-6和TNF-α水平升高。
  • 与C类相比,A1类中CCL3、CCL4、CCL2、CCL5、IL-1β、IL-15、IL-1Ra和G-CSF水平升高。
  • CCL3、CCL5、IL-15和IL-1Ra区分A1与C的AUC=1.00。
  • 决策树算法鉴别YEL-AEFI病因特异性定义的总体准确率为91%。
  • CCL3、CCL5、IL-15和IL-1Ra为识别A1的根属性,VEGF作为分支节点区分C(WT-YFV)与C*。

关键数值与推荐

  • CCL3、CCL5、IL-15和IL-1Ra区分A1与C的AUC=1.00。
  • 决策树算法总体准确率为91%。

临床怎么用

  • 可将CCL3、CCL5、IL-15、IL-1Ra和VEGF的血清检测纳入YEL-AEFI疑似病例的辅助鉴别诊断流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the present study, a range of serum biomarkers were quantified in suspected cases of adverse events following YF immunization (YEL-AEFI) to propose a reliable laboratorial algorithm to discriminate confirmed YEL-AEFI ("A1" class) from cases with other illnesses ("C" class). Our findings demonstrated that increased levels of CXCL8, CCL2, CXCL10, IL-1β, IL-6 and TNF-α were observed in YEL-AEFI ("A1" and "C" classes) as compared to primary vaccines without YEL-AEFI [PV(day 3-28)] and reference range (RR) controls. Notably, increased levels of CCL3, CCL4, CCL2, CCL5, IL-1β, IL-15, IL-1Ra and G-CSF were found in "A1" as compared to "C" class. Venn diagrams analysis allowed the pre-selection of biomarkers for further analysis of performance indices. Data demonstrated that CCL3, CCL5, IL-15 and IL-1Ra presented high global accuracy (AUC = 1.00) to discriminate "A1" from "C". Decision tree was proposed with a reliable algorithm to discriminate YEL-AEFI cases according to cause-specific definitions with outstanding overall accuracy (91%). CCL3, CCL5, IL-15 and IL-1Ra appears as root attributes to identify "A1" followed by VEGF as branch nodes to discriminate Wild Type YFV infection ("C(WT-YFV)") from cases with other illnesses ("C*"). Together, these results demonstrated the applicability of serum biomarker measurements as putative parameters towards the establishment of accurate laboratorial tools for complementary differential diagnosis of YEL-AEFI cases.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fradico JRB, Campi-Azevedo AC, Peruhype-Magalhães V, et al. CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions. Vaccine. 2021. PMID: 34147295. doi:10.1016/j.vaccine.2021.05.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。